Skip to main content

WELLS FARGO & COMPANY/MN

Position in CADL — Candel Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in CADL

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$81,305
-$336,223 QoQ
Shares Held
16,593
-77.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. CADL ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CADL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $81,305 16,593
2025-12-31 $417,528 73,899
2025-09-30 $134,186 26,311
2025-06-30 $105,121 20,775
2025-03-31 $76,777 13,589
2024-12-31 $87,858 10,122
2024-09-30 $42,875 6,187
2024-06-30 $39,332 6,344
2024-03-31 $181 115
2023-12-31 $166 113
2023-09-30 $99 108
2023-06-30 $131 104
2023-03-31 $135 100
2022-12-31 $175 98
2022-09-30 $301 96
2022-06-30 $197 61
2021-09-30 $11,425 1,054